BlackRock Institutional Trust’s Cymabay Therapeutics CBAY Stock Holding History

BlackRock Institutional Trust’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$80K	Hold	46,238	–	–	﹤0.01%	3669
2016 Q3	$90K	Hold	46,238	–	–	﹤0.01%	3707
2016 Q2	$80K	Hold	46,238	–	–	﹤0.01%	3734
2016 Q1	$62K	Hold	46,238	–	–	﹤0.01%	3773
2015 Q4	$78K	Hold	46,238	–	–	﹤0.01%	3775
2015 Q3	$90K	Hold	46,238	–	–	﹤0.01%	3742
2015 Q2	$124K	Buy	+46,238	New	+$190K	﹤0.01%	3696

Other funds holding CBAY

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return